Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
023910:KOSDAQ
Dai Han Pharm Co Ltd
₩27,950.00
+2.01%
(+550.00) 1D
May 22, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 023910...
Open
₩27,350
High
₩28,150
Low
₩27,350
Mkt. cap
167.70B
Avg. vol.
15.49K
Volume
14.56K
Dividend
3.58%
Quarterly dividend
₩250
Ex-dividend date
Dec 29, 2021
P/E ratio
5.95
52-wk high
₩33,950
52-wk low
₩26,950
EPS
₩4,701
Shares outstanding
6.00M
No. of employees
737
News stories
From sources across the web
About Dai Han Pharm Co Ltd
CEO-
Employees737
Founded1945
Headquarters-
SectorPharmaceutical industry
Websitedaihan.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
49.89B
51.49B
56.17B
51.06B
Cost of goods sold
32.77B
35.49B
37.79B
38.11B
Cost of revenue
32.77B
35.49B
37.79B
38.11B
Research and development expenses
674.09M
485.25M
432.31M
614.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.98B
7.57B
7.09B
8.37B
Operating expense
7.88B
8.25B
7.75B
9.38B
Total operating expenses
40.66B
43.75B
45.54B
47.49B
Operating income
9.23B
7.75B
10.64B
3.57B
Other non operating income
9.52M
22.94M
-12.03M
16.84M
EBT including unusual items
9.80B
7.95B
11.23B
4.17B
EBT excluding unusual items
9.66B
7.75B
11.26B
4.18B
Income tax expense
2.15B
1.75B
2.52B
-903.43M
Effective tax rate
21.95%
21.98%
22.39%
-21.65%
Other operating expenses
43.28M
35.71M
97.88M
273.08M
Net income
7.65B
6.20B
8.72B
5.08B
Net profit margin
15.33%
12.05%
15.52%
9.94%
Earnings per share
-
-
-
-
Interest and investment income
408.11M
454.00M
478.34M
526.28M
Interest expense
-522.70K
-623.39K
-722.02K
-819.90K
Net interest expenses
407.59M
453.37M
477.61M
525.46M
Depreciation and amortization charges
138.45M
147.02M
139.32M
140.33M
EBITDA
11.06B
9.74B
13.11B
6.50B
Gain or loss from assets sale
-10.00M
-19.39M
-2.00M
3.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer